Heart Health Inc. to Conduct a Feasibility Study on Product Placement for Heart Health Monitor

MONTREAL, QUEBEC, Oct 23 (MARKET WIRE) --
Heart Health, Inc. (PINK SHEETS: HHEL) is pleased to announce that the
Company is exploring an opportunity to engage a marketing and research
company to conduct a feasibility study concerning the product placement
of the Heart Health Monitor. Currently, cardiovascular products earn
approximately $29.4 billion in annual sales.

Heart Health Inc. intends to engage the services of a marketing and
research company to assist with conducting surveys to determine the size
and scope of the market for the one-lead, USB-enabled Heart Health
Monitor. Heart Health's goal is to ascertain the number of units the
Company would initially produce for its rollout and how to reach specific
target markets to reap the most benefits for its product. Research
companies provide customized, timely and relevant market research
solutions in a variety of areas from product positioning and total
unduplicated reach and frequency analysis, to focus groups and opinion
surveys.

"We have a great product that we believe will be an enormous benefit to
the medical community. Through this endeavor we want to determine the
best approach to market our Heart Health Monitor to reach the most
people, generate revenue and maximize our shareholders' value," stated
Michael Kron, Chairman and CEO of Heart Health, Inc.

Heart Health Inc. is in the process of finalizing the patent application
it will file with the U.S. Patent and Trademark Office for the USB
enabled Heart Health Monitor (HHM). The non-invasive HHM provides
on-demand EKG results for patients who either require monitoring, or have
a history of heart disease in the family. The device enables a trained
medical professional to make a more in depth diagnosis of the user's
heart condition.

About Heart Health, Inc.:

Heart Health, Inc. is focused on the development and marketing of
innovative, cardiovascular medical device products. The Company intends
to revolutionize the way in which people monitor the health of their
hearts using newly acquired products such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 that involves risks and uncertainties
including, but not limited to, the impact of competitive products, the
ability to meet customer demand, the ability to manage growth,
acquisitions of technology, equipment, or human resources, the effect of
economic business conditions, and the ability to attract and retain
skilled personnel. The Company is not obligated to revise or update any
forward-looking statements in order to reflect events or circumstances
that may arise after the date of this release.

Contacts:
Heart Health, Inc.
Investor Relations
1-866-THE APPL(E)

Copyright 2008, Market Wire, All rights reserved.

-0-